If you made any changes in Pure these will be visible here soon.

Personal profile


  • 2007 Ph.D. (Philosophy), Graduate Institute of Pharmacognosy, Taipei Medical University
  • 1999 M.S., School of Pharmacy, Taipei Medical University 


  • 2015 Visiting Scholars, Genomics Research Center, Academia Sinica, Taiwan
  • 2015 Reviewer for PLoS one
  • 2008, 2009 and 2013 Reviewer for Journal of Cellular Biochemistry


  • Associate Professor, Graduate Institute of Clinical Medicine, Taipei Medical University
  • 2014, Assistant Professor, Graduate Institute of Clinical Medicine, Taipei Medical University

Research Interests

  • Cancer Drug Discovery
  • Protein-Protein Interaction


Fingerprint Dive into the research topics where Yuan-Feng Lin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 28 Similar Profiles
Neoplasm Metastasis Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Sertoli Cells Medicine & Life Sciences
Chaperonin Containing TCP-1 Medicine & Life Sciences
Tubulin Medicine & Life Sciences
Type C Phospholipases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2015 2019

Research Output 2001 2019

  • 365 Citations
  • 13 h-Index
  • 36 Article

Adenylate kinase 4 modulates oxidative stress and stabilizes HIF-1α to drive lung adenocarcinoma metastasis

Jan, Y. H., Lai, T. C., Yang, C. J., Lin, Y. F., Huang, M. S. & Hsiao, M., Jan 29 2019, In : Journal of Hematology and Oncology. 12, 1, 12.

Research output: Contribution to journalArticle

Adenylate Kinase
Oxidative Stress
Neoplasm Metastasis
Lung Neoplasms
Epithelial-Mesenchymal Transition
Ovarian Neoplasms
Inhibitory Concentration 50
2 Citations (Scopus)
Triple Negative Breast Neoplasms
Drug Therapy
Kaplan-Meier Estimate
Inhibitory Concentration 50
1 Citation (Scopus)
Tubulin Modulators
G2 Phase Cell Cycle Checkpoints
Colorectal Neoplasms
1 Citation (Scopus)

OTUD7B upregulation predicts a poor response to paclitaxel in patients with triple-negative breast cancer

Chiu, H. W., Lin, H. Y., Tseng, I. J. & Lin, Y. F., Jan 1 2018, In : Oncotarget. 9, 1, p. 553-565 13 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Breast Neoplasms